Rigel Pharmaceuticals (RIGL) is Quietly Building a Biotech Empire
Rigel Pharmaceuticals (NASDAQ:RIGL) has quietly emerged as one of the most compelling under-the-radar biotech turnaround stories in the…
Wall Street’s Best-Kept Biotech Secret? Why Pharvaris (PHVS) Could Be the Next $3 Billion Breakout
Pharvaris NV is a clinical-stage biopharmaceutical company headquartered in Leiden, the Netherlands, that is redefining the future of…
Is Candel Therapeutics (CADL) the Next Big Cancer Stock? Analysts Say Yes—And It’s Still Cheap
Candel Therapeutics Inc. (NASDAQ:CADL) is a Massachusetts-based clinical-stage immuno-oncology company that traces its roots to pioneering gene-therapy research…
This Tiny Biotech Just Spiked 239%—Here’s Why BioNexus (BGLC) Could Go Even Higher
BioNexus Gene Lab Corp. (NASDAQ:BGLC) is a Malaysia-based, Wyoming-incorporated biotech that has evolved from a niche molecular-diagnostics start-up…
Forget the Headlines — Anavex (AVXL)’s Alzheimer’s Drug Could Change Everything
Anavex Life Sciences Corporation (NASDAQ:AVXL), is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for…
From Penny Stock to Powerhouse? AIM ImmunoTech (AIM)’s Comeback Could Be Epic
AIM ImmunoTech Inc. (NYSE:AIM) traces its roots to 1966, when the company—then known as Hemispherx Biopharma—set out to…
GlaxoSmithKline (GSK)’s Reinvention is Complete—Will This Drug Giant Deliver 50% Upside in 2025?
GlaxoSmithKline plc (NYSE:GSK), commonly referred to as GSK, is a global biopharmaceutical powerhouse headquartered in the United Kingdom…
Abeona (ABEO) Could Be Wall Street’s Next Biotech Darling
Abeona Therapeutics Inc. (NASDAQ:ABEO) is a commercial-stage biopharmaceutical company pioneering the development of gene and cell therapies for…
Pelthos Therapeutics (PTHS): Zero Debt, $50M in Cash, and an FDA Greenlight—What’s Not to Love?
Pelthos Therapeutics Inc. (NYSE:PTHS) is a newly minted, revenue-ready biopharmaceutical company that sprang to life on July 2,…
Biotech Bargain Alert: Theravance Biopharma (TBPH) May Offer Triple-Digit Upside in 2025
Theravance Biopharma Inc. (NASDAQ:TBPH) is a clinical-stage biopharmaceutical company that has steadily built a reputation for its focus…
Artelo Biosciences (ARTL): The $10M Company Targeting Billion-Dollar Markets
Artelo Biosciences, Inc. (NASDAQ: ARTL) is a clinical-stage pharmaceutical company based in Solana Beach, California, pioneering a novel…
Wall Street Is Sleeping on Tempest Therapeutics (TPST)—But Not For Long
Tempest Therapeutics, Inc. (NASDAQ:TPST) is a 2011-founded, Brisbane-based oncology innovator that has quietly risen from a niche research…
Forget Daily Pills—Intellia Therapeutics (NTLA) is Creating Cures You Only Need Once
Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a biotechnology company at the forefront of a genomic revolution, pioneering the development…
Nektar Therapeutics (NKTR) Skyrockets 350% in a Week!
Nektar Therapeutics (NASDAQ:NKTR) is a San Francisco-based biotechnology company that has spent over three decades pushing the boundaries…
Soleno Therapeutics (SLNO): The Biotech Company That Could Make You Rich
Soleno Therapeutics Inc. (NASDAQ:SLNO) is an innovative biotechnology company at the forefront of developing treatments for rare diseases…
Investing in Ultragenyx (RARE): The Biotech Stock With 100%+ Upside Potential
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is an innovative biotechnology company that has carved out a prominent position in the…
Exact Sciences (EXAS) Just Made Cancer Detection 100x Easier!
Exact Sciences Corporation (NASDAQ:EXAS) is a pioneering biotechnology company committed to improving the lives of patients through groundbreaking…
BioCryst (BCRX) is a Top Stock for Investors Focused on Rare Diseases
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX), headquartered in Research Triangle Park, North Carolina, is a pioneering biotechnology company committed to…